Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151742 | SCV000200120 | benign | not specified | 2013-06-11 | criteria provided, single submitter | clinical testing | This is the major allele (http://gnomad.broadinstitute.org/variant/10-43622217-T -C). |
Labcorp Genetics |
RCV001520525 | SCV001729634 | benign | Multiple endocrine neoplasia, type 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001795262 | SCV002033571 | benign | Multiple endocrine neoplasia type 2A | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001795263 | SCV002033574 | benign | Multiple endocrine neoplasia type 2B | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001795261 | SCV002033575 | benign | Pheochromocytoma | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genetics and Molecular Pathology, |
RCV001520525 | SCV002761349 | benign | Multiple endocrine neoplasia, type 2 | 2019-08-06 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001795263 | SCV004017337 | benign | Multiple endocrine neoplasia type 2B | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004718060 | SCV005319285 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004739477 | SCV000313726 | benign | RET-related disorder | 2022-01-07 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |